| Literature DB >> 24854737 |
Yingwei Qiu1, Xiaofei Lv2, Huanhuan Su3, Guihua Jiang3, Cheng Li4, Junzhang Tian3.
Abstract
BACKGROUND ANDEntities:
Mesh:
Year: 2014 PMID: 24854737 PMCID: PMC4031192 DOI: 10.1371/journal.pone.0098346
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Demographic and Clinical Characteristics for End Stage Renal Disease (ESRD) Patients and Controls.
|
|
| ||||
| ESRD Patients (N = 30) | Controls (N = 30) | ||||
| Mean | SD | Mean | SD | P | |
| Age (years) | 38.8 | 9.6 | 38.1 | 7.0 | 0.737 |
| Education (years) | 9.8 | 5.1 | 10.6 | 4.5 | 0.506 |
| Laboratory tests | |||||
| S. uric acid (mg/dl) | 5.98 | 1.20 | N/A | N/A | - |
| S. urea (mmol/l) | 19.2 | 5.4 | N/A | N/A | - |
| S. calcium (mmol/l) | 2.32 | 0.25 | N/A | N/A | - |
| S. Phosphorus (mmol/l) | 1.30 | 0.24 | N/A | N/A | - |
| Illness duration (years) | 12.5 | 4.8 | N/A | N/A | - |
| Dialysis duration (mouths) | 17.2 | 6.8 | N/A | N/A | - |
| Mean hemodialysis duration (h/w) | 14.5 | 3.5 | N/A | N/A | - |
| N | % | N | % | P | |
| Gender | |||||
| Female | 7 | 23.3 | 9 | 30 | 0.559 |
| Male | 23 | 76.7 | 21 | 70 | 0.559 |
There were no significant differences in age (p = 0.737), education (p = 0.506), sex composition (p = 0.559) between ESRD patients and controls.
Note. N/A = not applicable.
Blood pressure systolic, Blood pressure diastolic and Hematocrit of the ESRD patients at the start and end of hemodialysis treatment session.
|
|
|
|
|
| Blood pressure systolic (mm Hg) | 143±21 | 138±19 | 0.67 |
| Blood pressure diastolic (mm Hg) | 81±8 | 83±7 | 0.52 |
| Hematocrit (vol%) | 36.1±3.12 | 36.7±3.75 | 0.46 |
Figure 1Statistical Parametric Images of Voxel-Based Morphometry Analysis for ESRD Patients and controls (Panels A: slices view, Panels B: whole brain rendering).
Relative to controls, ERSD patients had significantly reduced gray matter volume in the bilateral medial orbitofrontal cortex, bilateral dorsal lateral prefrontal cortex and right middle temporal gyrus.
Significant differences between ESRD Patients and Controls in resting state functional connectivity for the four seed areas (showed different in group comparison) and the rest of the brain.
|
|
|
|
|
|
|
|
|
| ||||||
| Bilateral medial OFC | Right cerebellum posterior lobe | 388 | 36, −84, −33 | −5.5361 | −0.28 | −0.04 |
| Left cerebellum posterior lobe | 258 | −36, −78, −45 | −4.059 | −0.28 | −0.03 | |
| right dlPFC (8,9,10) | 139 | 24,51,36 | −4.371 | −0.13 | 0.08 | |
| bilateral ACC(23,24,31) | 234 | 18, −39,36 | −4.6875 | −0.10 | 0.08 | |
| Right DLPFC | Left Cerebellum Posterior Lobe | 92 | −48, −72, −48 | −4.1573 | −0.15 | 0.05 |
| Right Cerebellum Posterior Lobe | 89 | 24, −93, −30 | −5.196 | −0.19 | 0.01 | |
| Left Inferior Temporal Gyrus (20) | 120 | −48, −15, −36 | −4.625 | −0.14 | 0.07 | |
| right dlPFC | 110 | 42,33,42 | −3.749 | −0.11 | 0.10 | |
|
| ||||||
| Bilateral medial OFC | Left OFC (10, 11, 32) | 276 | −21,42, −15 | 5.0312 | 0.49 | 0.21 |
| Right OFC (10, 11) | 153 | 21,45, −3 | 4.8567 | 0.56 | 0.25 | |
| Left superior parietal lobe (4,5,7) | 127 | −12, −45,75 | 4.0437 | 0.14 | −0.08 | |
| Right superior parietal lobe (7) | 108 | 24, −81,51 | 4.7056 | 0.11 | −0.12 | |
| Left DLPFC | Left Superior Temporal Gyrus (38) | 100 | −45,3, −18 | 4.6605 | 0.09 | −0.15 |
| Right DLPFC | Bilateral OFC (10,11,25,38,47) | 366 | 0,48, −30 | 4.5486 | 0.23 | 0.01 |
| Bilateral postcentral gyrus (1,2,3,4,5,6) | 110 | −36, −39,66 | 4.8554 | 0.13 | −0.07 | |
| Left middle temporal gyurs | Right medial PFC (10,32) | 129 | 6 63 9 | 4.2882 | 0.12 | −0.09 |
All the coordinates are donated by Montreal Neurological Institute (MNI) space coordinates. t-score donates the statistic value of two sample t-test by contrasting ESRD patients to controls at p<0.05 AlphaSim corrected.
Figure 2Statistical Parametric Images of Between-Group Functional Connectivity Analysis for ESRD Patients and Controls.
Panels A demonstrated enhanced functional connectivity in superior temporal gyrus (Red) in ESRD patients when the seed areas were located in the left dorsal lateral prefrontal cortex ([Brodmann's area 10], panels B demonstrated reduced functional connectivity in bilateral cerebellum posterior lobe, left inferior temporal gyrus, right dlPFC (Blue), and enhanced functional connectivity in bilateral OFC, left posterior gyrus (Red) in ESRD patients when the seed areas were located in the right dorsal lateral prefrontal cortex ([Brodmann's area 11], panels C demonstrated reduced functional connectivity in bilateral cerebellum posterior lobe, right dlPFC, bilateral ACC (Blue), enhanced FC in bilateral OFC, bilateral superior parietal lobe (Red) when the seed areas were located in the medial orbito-frontal cortex ([Brodmann's area 10, 11, 32], and panels D demonstrated enhanced functional connectivity in right medial PFC (Red) in ESRD patients when the seed areas were located in the left middle temporal gyrus [Brodmann's area 10, 11, 32].